Total raised
$30.5M
Last stage
Series A
Investors
Dov Gertz
Holds a master's in bioinformatics from Tel Aviv University. Developed a machine-learning method for discovering novel CRISPR systems, leading to a U.S.-licensed patent and a publication with Nobel laureate Jennifer Doudna.
LinkedInOded Kalev
ML expert and former cybersecurity AI lead; previously managed an R&D group of 20 engineers and ML experts at Perception Point. Has advised U.S. government agencies on large-scale generative AI applications.
LinkedInIddo Weiner
Formerly VP of Research at BiomX. Completed his PhD in engineering and biology in two and a half years with ten peer-reviewed papers. Has led two drug programs to successful Phase 2 clinical readouts.
LinkedInNo applications, no recruiter spam. Just the intro.
A few questions to make sure this role is the right shape for you. Two minutes.
I write the intro, send it to the founder, and handle the back-and-forth.
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.